Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PMD Healthcare is a digital health company that specializes in the development of remote monitoring solutions for chronic respiratory conditions. The company is best known for SpiroPD, the first FDA-cleared personal lung function meter designed to help patients manage diseases such as COPD, asthma, and cystic fibrosis from home. By integrating handheld spirometry with a cloud-based wellness management system, PMD Healthcare allows for the real-time tracking of lung health and facilitates proactive communication between patients and clinicians. This technology aims to improve patient outcomes by identifying early signs of exacerbation and reducing the need for emergency care. In January 2022, PMD Healthcare was acquired by NuvoAir, a leader in digital respiratory health, to enhance its remote patient monitoring capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PMD Healthcare.